Synopsis
Synopsis
0
USDMF
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
VMF
0
API
0
FDF
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
DRUG PRODUCT COMPOSITIONS
0
EDQM
0
USP
0
JP
0
Others
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
US Medicaid
NA
Annual Reports
NA
Finished Drug Prices
NA
1. Klh-2109 Choline
2. Vhs6sc660q
3. 1321816-57-2
4. Obe2109 Choline
5. Unii-vhs6sc660q
6. Linzagolix Choline [usan]
7. Ethanaminium, 2-hydroxy-n,n,n-trimethyl-, 3-(5-((2,3-difluoro-6-methoxyphenyl)methoxy)-2-fluoro-4-methoxyphenyl)-1,2,3,4-tetrahydro-2,4-dioxothieno(3,4-d)pyrimidine-5-carboxylate (1:1)
8. Linzagolix Choline (usan)
9. Linzagolix Choline Salt
10. Linzagolix Choline [who-dd]
11. Chembl4298171
12. Dtxsid201337397
13. Bcp30450
14. Akos040747106
15. D11609
16. 3-[5-[(2,3-difluoro-6-methoxyphenyl)methoxy]-2-fluoro-4-methoxyphenyl]-2,4-dioxo-1h-thieno[3,4-d]pyrimidine-5-carboxylate;2-hydroxyethyl(trimethyl)azanium
Molecular Weight | 611.6 g/mol |
---|---|
Molecular Formula | C27H28F3N3O8S |
Hydrogen Bond Donor Count | 2 |
Hydrogen Bond Acceptor Count | 12 |
Rotatable Bond Count | 8 |
Exact Mass | g/mol |
Monoisotopic Mass | g/mol |
Topological Polar Surface Area | 166 |
Heavy Atom Count | 42 |
Formal Charge | 0 |
Complexity | 867 |
Isotope Atom Count | 0 |
Defined Atom Stereocenter Count | 0 |
Undefined Atom Stereocenter Count | 0 |
Defined Bond Stereocenter Count | 0 |
Undefined Bond Stereocenter Count | 0 |
Covalently Bonded Unit Count | 2 |
Yselty is indicated for the treatment of moderate to severe symptoms of uterine fibroids in adult women of reproductive age.
H01CC04
ABOUT THIS PAGE
LOOKING FOR A SUPPLIER?